Glossary · Treatments and drug classes

Aromatase inhibitor

Also called AI, estrogen blocker, aromatase inhibitors

Medically reviewed by Johnathan Chance Miller, M.D. —

Physician and holistic medicine practitioner blending rigorous clinical training with an integrative approach to longevity. Full bio

An aromatase inhibitor is a medicine that blocks aromatase, the enzyme that converts androgens, including testosterone, into estrogen. Aromatase works in many tissues, including body fat, so blocking it lowers the amount of estrogen the body makes.

FDA-approved examples are anastrozole (sold as Arimidex), letrozole (sold as Femara) and exemestane (sold as Aromasin). Their approved use is treating breast cancer in women who have been through menopause, where lowering estrogen can slow or stop tumors that need it to grow. Lowering estrogen also has costs: the class can reduce bone density and cause joint, bone and muscle pain.

Why it matters after 45

Most people meet this class in one of two ways in midlife. Women meet it in breast cancer care after menopause. Men on testosterone therapy meet it because testosterone converts to estradiol, and blocking that conversion is often raised as a way to control the estradiol result. Estrogen helps regulate bone in men as well as women, which is why the testosterone pages on this site explain why a raised estradiol result alone is usually not treated this way.

How aromatase inhibitors work

Aromatase is the last step in making estrogen: it turns androgens such as testosterone and androstenedione into estradiol and estrone. The process is called aromatization. Before menopause, most of a woman's estrogen comes from the ovaries. After menopause, and in men, most comes from aromatase working in other tissues, especially body fat. Blocking the enzyme therefore cuts estrogen most effectively when the ovaries are no longer the main source.

That is why, according to the National Cancer Institute, aromatase inhibitors are used mainly in postmenopausal women: before menopause the ovaries make too much aromatase for the drugs to block effectively. Premenopausal women can take them only alongside a medicine that switches off the ovaries.

MedlinePlus classes anastrozole and letrozole as nonsteroidal aromatase inhibitors. Exemestane works on the same enzyme but has a steroid structure. All three are used in similar situations.

How they differ from other "estrogen blockers"

"Estrogen blocker" is used loosely for at least three different kinds of medicine:

  • Aromatase inhibitors lower how much estrogen the body makes.
  • SERMs (selective estrogen receptor modulators), such as tamoxifen, leave estrogen levels alone and instead block estrogen's effect in some tissues while acting like estrogen in others. See SERM.
  • SERDs (selective estrogen receptor degraders), such as fulvestrant, bind to estrogen receptors and lead to their breakdown.

All three are used in hormone receptor-positive breast cancer, sometimes one after another. They are not interchangeable, and some over-the-counter supplements sold as "estrogen blockers" are none of these.

Approved uses

In the United States, anastrozole, letrozole and exemestane are FDA-approved for breast cancer in postmenopausal women, including early breast cancer after other treatment and cancer that has spread or worsened. The NCI notes they are also used in men with advanced breast cancer, together with a drug that suppresses testosterone production. Lowering testosterone-driven estradiol in men on testosterone therapy is not an approved use, so any such prescription is off-label.

Side effects

Because they lower estrogen, aromatase inhibitors produce effects much like estrogen loss. MedlinePlus lists hot flashes, joint, bone and muscle pain, tiredness, trouble sleeping and vaginal dryness among the common ones for anastrozole and letrozole. Both can decrease bone density and raise the chance of fractures, which is why bone health is watched during long-term use. In men, estrogen supports bone and sex drive, so pushing estradiol too low can cause the problems it normally prevents.

Common questions

What is an aromatase inhibitor?

A medicine that blocks aromatase, the enzyme that turns testosterone and other androgens into estrogen, so the body makes less estrogen.

Are aromatase inhibitors the same as estrogen blockers?

They are one kind. "Estrogen blocker" can also mean a SERM such as tamoxifen, which blocks estrogen's action rather than its production, or a SERD such as fulvestrant.

Why are aromatase inhibitors used only after menopause?

Before menopause the ovaries make too much aromatase for the drugs to block on their own. Premenopausal women take them only together with a medicine that suppresses the ovaries.

Do men on TRT need an aromatase inhibitor?

That is a clinical decision, and it is not an approved use. Estradiol normally rises somewhat on testosterone therapy, and estrogen protects bone and libido in men, so a raised estradiol result on its own is usually not a reason to block it. The case is laid out in High estradiol in men.

References

  1. MedlinePlus. Anastrozole. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a696018.html
  2. MedlinePlus. Letrozole. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a698004.html
  3. MedlinePlus. Exemestane. U.S. National Library of Medicine. https://medlineplus.gov/druginfo/meds/a607006.html
  4. National Cancer Institute. Hormone Therapy for Breast Cancer. https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet
  5. MedlinePlus Genetics. CYP19A1 gene. U.S. National Library of Medicine. https://medlineplus.gov/genetics/gene/cyp19a1/
  6. MedlinePlus. Estrogen Levels Test. U.S. National Library of Medicine. https://medlineplus.gov/lab-tests/estrogen-levels-test/

Definitions here are educational and are not medical advice. They explain what a term means; the pages linked above cover what it means for you. Editorial & medical review policy · All glossary terms

See if you're eligibleA short, confidential online assessment. Reviewed by a clinician.